XTX Topco Ltd Buys 6,104 Shares of Doximity, Inc. (NASDAQ:DOCS)

XTX Topco Ltd lifted its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 28.2% in the second quarter, according to its most recent filing with the SEC. The fund owned 27,770 shares of the company’s stock after acquiring an additional 6,104 shares during the period. XTX Topco Ltd’s holdings in Doximity were worth $777,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in DOCS. William Blair Investment Management LLC bought a new stake in Doximity in the first quarter worth $148,823,000. Swedbank AB bought a new stake in Doximity in the first quarter worth $91,673,000. Norges Bank bought a new stake in Doximity in the fourth quarter worth $35,995,000. Capital World Investors lifted its stake in Doximity by 250.7% in the first quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock worth $46,143,000 after purchasing an additional 1,225,707 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its stake in Doximity by 33.5% in the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock worth $66,594,000 after purchasing an additional 621,590 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on DOCS shares. Barclays boosted their price target on shares of Doximity from $31.00 to $35.00 and gave the stock an “equal weight” rating in a research note on Friday, August 9th. Robert W. Baird boosted their price objective on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research report on Tuesday, September 17th. Needham & Company LLC upgraded shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a research report on Friday, August 9th. Baird R W upgraded shares of Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. Finally, Morgan Stanley boosted their price objective on shares of Doximity from $25.00 to $26.00 and gave the company an “underweight” rating in a research report on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $32.42.

Insiders Place Their Bets

In other Doximity news, Director Watkin Phoebe L. Yang sold 1,011 shares of the company’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $25.54, for a total value of $25,820.94. Following the sale, the director now owns 11,258 shares in the company, valued at $287,529.32. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Doximity news, Director Watkin Phoebe L. Yang sold 1,011 shares of the company’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $25.54, for a total value of $25,820.94. Following the sale, the director now owns 11,258 shares in the company, valued at $287,529.32. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Watkin Phoebe L. Yang sold 1,940 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $28.22, for a total transaction of $54,746.80. Following the completion of the sale, the director now owns 12,269 shares in the company, valued at approximately $346,231.18. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 37,951 shares of company stock worth $1,271,018. 39.40% of the stock is currently owned by company insiders.

Doximity Price Performance

Shares of NASDAQ DOCS opened at $40.88 on Monday. Doximity, Inc. has a 1 year low of $19.71 and a 1 year high of $41.05. The company’s 50-day moving average is $33.47 and its 200 day moving average is $29.09. The stock has a market capitalization of $7.58 billion, a P/E ratio of 56.78, a P/E/G ratio of 5.15 and a beta of 1.27.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.06. The company had revenue of $126.68 million for the quarter, compared to analysts’ expectations of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. Research analysts anticipate that Doximity, Inc. will post 0.8 earnings per share for the current year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.